Sarepta has received US FDA approval for updated prescribing information for Elevidys, an AAV-based gene transfer therapy.

The grantmaking organization Open Philanthropy has awarded funding for a University of California San Diego technology ...

Entrepreneurs say it’s time to safety-test designer baby technology. A West Coast biotech entrepreneur says he’s secured $30 million to form a public-benefit company to study how to safely create ...

Non-exclusive license providing Solid’s proprietary, next-generation capsid, AAV-SLB101, to Andelyn Biosciences, a ...

Asan Medical Center in Seoul has transferred its stem cell therapy technology, developed for the treatment of intractable ...

Vgenomics offers RgenX, an AI-powered cloud platform that diagnoses rare genetic diseases and accelerates drug discovery by ...

With a recent breakthrough in genetic technology, producers can expect to achieve the same embryo numbers from half the ...

How AI, robotics, and precision medicine are transforming cancer care—bridging hope, technology, and humanity in the ongoing ...

Australian agri-biotech company Nbryo has completed a $10m capital raising to accelerate genetic improvement in the global ...

MeiraGTx’s AAV-AIPL1 has already led to vision gains in blind children, as regulatory submissions for the gene therapy close ...

Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Bio-Gene Technology Ltd. ( (AU:BGT)) has ...